Innovation and the Pharmaceutical Industry : Critical Reflections on the Virtues of Profit

  • ISBN13:


  • ISBN10:


  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2008-04-01
  • Publisher: Scrivener Pub

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

List Price: $69.00 Save up to $17.25
  • Buy Used
    Add to Cart Free Shipping Icon Free Shipping


Supplemental Materials

What is included with this book?


Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally.

Author Biography

H. Tristram Engelhardt, Jr., holds degrees in both medicine and philosophy. He is Professor in the Department of Philosophy at Rice University, Professor Emeritus in the Department of Medicine, Baylor College of Medicine. In addition to having authored over 300 articles and chapters of books, as well as having authored or co-edited more than 30 volumes, he is the senior editor of The Journal of Medicine and Philosophy. Jeremy R. Garrett, M.A., is Ph.D. Candidate, Department of Philosophy, Rice University

Table of Contents

Prefacep. v
Pharmaceutical Innovation and the Market: The Pursuit of Profit and the Amelioration of the Human Conditionp. 1
The Social Responsibility of Pursuing Profit
The Unavoidable Goodness of Profit: The Cunning of Reason and the Realization of Human Well-Beingp. 17
Corporate Social Responsibility and Business Ethics in the Pharmaceutical Industryp. 33
Pharmaceutical Companies and Their Obligations to Developing Countries: Psychopaths or Scapegoats?p. 46
Autonomy, Advertising, and Pharmaceutical Costs
Autonomy, Constraining Options, and Pharmaceutical Costsp. 67
Pharmaceutical Advertising and Patient Autonomyp. 80
Some Criticisms of the Pharmaceutical Industry Critically Re-Examined
Why America Does Not Have a Second Drug Problemp. 100
Global Drug Innovation in a World of Financial Finitude: Retailing Virtue to Promote Capital Formation and Profitp. 128
Markets, Pharmaceuticals, and Health Savings Accounts
Time, Money, and the Market for Drugsp. 153
Perils of Parallel Trade: Reimporting Prescription Drugs from Canada to the U.S.p. 184
Pharmaceutical Liability: Another Source of Health Care Costs
Risk, Responsibility, and Litigationp. 193
Contributorsp. 231
Indexp. 233
Table of Contents provided by Ingram. All Rights Reserved.

Rewards Program

Reviews for Innovation and the Pharmaceutical Industry : Critical Reflections on the Virtues of Profit (9780980209440)